The antimicrobial mechanism of action of epsilon-poly-L-lysine

Applied and Environmental Microbiology

Volumn 80, Issue 24, 2014, Pages 7758-7770

  Hyldgaard, Morten ^a,b   Mygind, Tina ^b   Vad, Brian S ^a   Stenvang, Marcel ^a   Otzen, Daniel E ^a   Meyer, Rikke L ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b DUPONT COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; ATOMIC FORCE MICROSCOPY; CELL MEMBRANES; ESCHERICHIA COLI; FOOD PRESERVATIVES; PHOSPHOLIPIDS; POSITIVE IONS;

ANTI-MICROBIAL ACTIVITY; ANTIMICROBIAL MECHANISMS; CYTOPLASMIC MEMBRANE; MORPHOLOGICAL CHANGES; NATURAL-ANTIMICROBIALS; NEGATIVELY CHARGED MEMBRANES; SUPPORTED LIPID BILAYERS; SUSPENDED MEMBRANES;

LIPID BILAYERS;

CATION; GERM CELL; LIPID; MEMBRANE; MICROBIAL ACTIVITY; PEPTIDE; PERMEABILITY; PHOSPHOLIPID; POLYSACCHARIDE;

ESCHERICHIA COLI; LISTERIA INNOCUA;

ANTIINFECTIVE AGENT; POLYLYSINE;

CELL MEMBRANE; CHEMISTRY; DRUG EFFECTS; ESCHERICHIA COLI; LISTERIA; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL;

ANTI-BACTERIAL AGENTS; BIOLOGICAL TRANSPORT; CELL MEMBRANE; ESCHERICHIA COLI; LISTERIA; POLYLYSINE;

EID: 84917679658     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.02204-14     Document Type: Article

References (60)

1. Russell NJ, Gould GW. 2003. Major, new, and emerging food-poisoning and food-spoilage microorganisms, p 1-13. In Food preservatives. Kluwer Academic/Plenum Publishers, Dordrecht, Netherlands.
2. Baird-Parker TC. 2000. The production of microbiologically safe and stable foods, p 3-18. In Lund B, Baird-Parker TC, GouldGW(ed), Microbiological safety and quality of food. Springer-Verlag, Berlin, Germany.
3. Shima S. 1984. Antimicrobial action of ε-poly-L-lysine. J. Antibiot. 37: 1449. http://dx.doi.org/10.7164/antibiotics.37.1449.
4. Brandt AL, Castillo A, Harris KB, Keeton JT, Hardin MD, Taylor TM. 2010. Inhibition of Listeria monocytogenes by food antimicrobials applied singly and in combination. J. Food Sci. 75:M557-M563. http://dx.doi.org/10.1111/j.1750-3841.2010.01843.x.
5. Geornaras I, Sofos JN. 2005. Activity of ε-polylysine against Escherichia coli O157:H7, Salmonella Typhimurium, and Listeria monocytogenes. J. Food Sci. 70:M404-M408.
6. Chang S-S, Lu W-YW, Park S-H, Kang D-H. 2010. Control of foodborne pathogens on ready-to-eat roast beef slurry by ε-polylysine. Int. J. Food Microbiol. 141:236-241. http://dx.doi.org/10.1016/j.ijfoodmicro.2010.05.021.
7. Moschonas G, Geornaras I, Stopforth JD, Wach D, Woerner DR, Belk KE, Smith GC, Sofos JN. 2012. Activity of caprylic acid, Carvacrol, ε-polylysine, and their combinations against Salmonella in not-ready-toeat surface-browned, frozen, breaded chicken products. J. Food Sci. 77: M405-M411. http://dx.doi.org/10.1111/j.1750-3841.2012.02757.x.
8. Yoshida T, Nagasawa T. 2003. ε-Poly-L-lysine: microbial production, biodegradation and application potential. Appl. Microbiol. Biotechnol. 62:21-26. http://dx.doi.org/10.1007/s00253-003-1312-9.
9. Yamanaka K, Maruyama C, Takagi H, Hamano Y. 2008. ε-Poly-L-lysine dispersity is controlled by a highly unusual nonribosomal peptide synthetase. Nat. Chem. Biol. 4:766-772. http://dx.doi.org/10.1038/nchembio.125.
10. Takehara M, Hibino A, Saimura M, Hirohara H. 2010. High-yield production of short chain length poly(ε-L-lysine) consisting of 5-20 residues by Streptomyces aureofaciens, and its antimicrobial activity. Biotechnol. Lett. 32:1299-1303. http://dx.doi.org/10.1007/s10529-010-0294-9.
11. Hamano Y. 2011. Occurrence, biosynthesis, biodegradation, and industrial and medical applications of a naturally occurringε-poly-L-lysine. Biosci. Biotechnol. Biochem. 75:1226-1233. http://dx.doi.org/10.1271/bbb.110201.
12. Shima S, Sakai H. 1977. Polylysine produced by Streptomyces. Agric. Biol. Chem. 41:1807-1809. http://dx.doi.org/10.1271/bbb1961.41.1807.
13. Neda K, Sakurai T, Takahashi M, Aiuchi M, Ohgushi M. 1999. Twogeneration reproduction study with teratology test of ε-poly-L-lysine by dietary administration in rats. Jpn. Pharmacol. Ther. 27:28-29.
14. Kido Y, Hiramoto S, Murao M, Horio Y, Miyazaki T, Kodama T, Nakabou Y. 2003. Epsilon-polylysine inhibits pancreatic lipase activity and suppresses postprandial hypertriacylglyceridemia in rats. J. Nutr. 133:1887-1891.
15. Russell AD. 2002. Mechanisms of antimicrobial action of antiseptics and disinfectants: an increasingly important area of investigation. J. Antimicrob. Chemother. 49:597-599. http://dx.doi.org/10.1093/jac/49.4.597.
16. Vaara M. 1992. Agents that increase the permeability of the outer membrane. Microbiol. Rev. 56:395-411.
17. Nikaido H. 1994. Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science 264:382-388. http://dx.doi.org/10.1126/science.8153625.
18. Nikaido H. 2003. Molecular basis of bacterial outer membrane permeability revisited. Microbiol. Mol. Biol. Rev. 67:593-656. http://dx.doi.org/10.1128/MMBR.67.4.593-656.2003.
19. Yeaman MR, Yount NY. 2003. Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev. 55:27-55. http://dx.doi.org/10.1124/pr.55.1.2.
20. Melo MN, Ferre R, Castanho MARB. 2009. Antimicrobial peptides: linking partition, activity, and high membrane-bound concentrations. Nat. Rev. Microbiol. 7:245-250. http://dx.doi.org/10.1038/nrmicro2095.
21. Shai Y, Oren Z. 2001. From "carpet" mechanism to de novo-designed diastereomeric cell-selective antimicrobial peptides. Peptides 22:1629-1641. http://dx.doi.org/10.1016/S0196-9781(01)00498-3.
22. Sengupta D, Leontiadou H, Mark AE, Marrink S-J. 2008. Toroidal pores formed by antimicrobial peptides show significant disorder. Biochim. Biophys. Acta Biomembr. 1778:2308-2317. http://dx.doi.org/10.1016/j.bbamem.2008.06.007.
23. Teixeira V, Feio MJ, Bastos M. 2012. Role of lipids in the interaction of antimicrobial peptides with membranes. Prog. Lipid Res. 51:149-177. http://dx.doi.org/10.1016/j.plipres.2011.12.005.
24. Glukhov E, Stark M, Burrows LL, Deber CM. 2005. Basis for selectivity of cationic antimicrobial peptides for bacterial versus mammalian membranes. J. Biol. Chem. 280:33960-33967. http://dx.doi.org/10.1074/jbc. M507042200.
25. Vad BS, Bertelsen K, Johansen CH, Pedersen JM, Skrydstrup T, Nielsen NC, Otzen DE. 2010. Pardaxin permeabilizes vesicles more efficiently by pore formation than by disruption. Biophys. J. 98:576-585. http://dx.doi.org/10.1016/j.bpj.2009.08.063.
26. Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson MA, Roy SL, Jones JL, Griffin PM. 2011. Foodborne illness acquired in the United States: major pathogens. Emerg. Infect. Dis. 17:7-15. http://dx.doi.org/10.3201/eid1701.P11101.
27. Jadhav S, Shah R, Bhave M, Palombo EA. 2013. Inhibitory activity of yarrow essential oil on Listeria planktonic cells and biofilms. Food Control 29:125-130. http://dx.doi.org/10.1016/j.foodcont.2012.05.071.
28. Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y, Baba M, Datsenko KA, Tomita M, Wanner BL, Mori H. 2006. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol. Syst. Biol. 2:2006.2008. http://dx.doi.org/10.1038/msb4100050.
29. Miles AA, Misra SS, Irwin JO. 1938. The estimation of the bactericidal power of the blood. Epidemiol. Infect. 38:732-749.
30. Meyer RL, Zhou X, Tang L, Arpanaei A, Kingshott P, Besenbacher F. 2010. Immobilisation of living bacteria for AFM imaging under physiological conditions. Ultramicroscopy 110:1349-1357. http://dx.doi.org/10.1016/j.ultramic.2010.06.010.
31. Watson ML. 1958. Staining of tissue sections for electron microscopy with heavy metals. J. Biophys. Biochem. Cytol. 4:475-478. http://dx.doi.org/10.1083/jcb.4.4.475.
32. Reynolds ES. 1963. The use of lead citrate at high pH as an electronopaque stain in electron microscopy. J. Cell Biol. 17:208-212. http://dx.doi.org/10.1083/jcb.17.1.208.
33. Angelova MI, Dimitrov DS. 1986. Liposome electroformation. Faraday Discussions Chem. Soc. 81:303-311. http://dx.doi.org/10.1039/dc9868100303.
34. Najjar MB, Kashtanov D, Chikindas ML. 2007. ε-Poly-L-lysine and nisin A act synergistically against Gram-positive food-borne pathogens Bacillus cereus and Listeria monocytogenes. Lett. Appl. Microbiol. 45:13-18. http://dx.doi.org/10.1111/j.1472-765X.2007.02157.x.
35. Ye R, Xu H, Wan C, Peng S, Wang L, Xu H, Aguilar ZP, Xiong Y, Zeng Z, Wei H. 2013. Antibacterial activity and mechanism of action of ε-poly-L-lysine. Biochem. Biophys. Res. Commun. 439:148-153. http://dx.doi.org/10.1016/j.bbrc.2013.08.001.
36. Chang V, Chen L-Y, Wang A, Yuan X. 2010. The effect of lipopolysaccharide core structure defects on transformation efficiency in isogenic Escherichia coli BW25113 rfaG, rfaP, and rfaC mutants. J. Exp. Microbiol. Immunol. 14:101-107.
37. Vaara M, Vaara T. 1983. Polycations as outer membrane-disorganizing agents. Antimicrob. Agents Chemother. 24:114-122. http://dx.doi.org/10.1128/AAC.24.1.114.
38. Yethon JA, Heinrichs DE, Monteiro MA, Perry MB, Whitfield C. 1998. Involvement of waaY, waaQ, and waaP in the modification of Escherichia coli lipopolysaccharide and their role in the formation of a stable outer membrane. J. Biol. Chem. 273:26310-26316. http://dx.doi.org/10.1074/jbc.273.41.26310.
39. Yethon JA, Vinogradov E, Perry MB, Whitfield C. 2000. Mutation of the lipopolysaccharide core glycosyltransferase encoded by waaG destabilizes the outer membrane of Escherichia coli by interfering with core phosphorylation. J. Bacteriol. 182:5620-5623. http://dx.doi.org/10.1128/JB.182.19.5620-5623.2000.
40. Allende D, McIntosh TJ. 2003. Lipopolysaccharides in bacterial membranes act like cholesterol in eukaryotic plasma membranes in providing protection against melittin-induced bilayer lysis. Biochemistry 42:1101-1108. http://dx.doi.org/10.1021/bi026932s.
41. Danese PN, Pratt LA, Kolter R. 2000. Exopolysaccharide production is required for development of Escherichia coli K-12 biofilm architecture. J. Bacteriol. 182:3593-3596. http://dx.doi.org/10.1128/JB.182.12.3593-3596.2000.
42. Lee SM, Chen J. 2004. Survival of Escherichia coli O157:H7 in set yogurt as influenced by the production of an exopolysaccharide, colanic acid. J. Food Prot. 67:252-255.
43. Postupalenko VY, Shvadchak VV, Duportail G, Pivovarenko VG, Klymchenko AS, Mély Y. 2011. Monitoring membrane binding and insertion of peptides by two-color fluorescent label. Biochim. Biophys. Acta Biomembr. 1808:424-432. http://dx.doi.org/10.1016/j.bbamem.2010.09.013.
44. Schmidt NW, Mishra A, Lai GH, Davis M, Sanders LK, Tran D, Garcia A, Tai KP, McCray PB, Ouellette AJ, Selsted ME, Wong GCL. 2011. Criterion for amino acid composition of defensins and antimicrobial peptides based on geometry of membrane destabilization. J. Am. Chem. Soc. 133:6720-6727. http://dx.doi.org/10.1021/ja200079a.
45. Bo T, Liu M, Zhong C, Zhang Q, Su QZ, Tan ZL, Han PP, Jia SR. 2014. Metabolomic analysis of antimicrobial mechanisms of e-poly-L-lysine on Saccharomyces cerevisiae. J. Agric. Food Chem. 62:4454-4465. http://dx.doi.org/10.1021/jf500505n.
46. Epand RM, Epand RF. 2009. Domains in bacterial membranes and the action of antimicrobial agents. Mol. Biosyst. 5:580-587. http://dx.doi.org/10.1039/b900278m.
47. Fischer W, Leopold K. 1999. Polar lipids of four Listeria species containing L-lysylcardiolipin, a novel lipid structure, and other unique phospholipids. Int. J. Syst. Bacteriol. 49:653-662. http://dx.doi.org/10.1099/00207713-49-2-653.
48. Tack BF, Sawai MV, Kearney WR, Robertson AD, Sherman MA, Wang W, Hong T, Boo LM, Wu H, Waring AJ, Lehrer RI. 2002. SMAP-29 has two LPS-binding sites and a central hinge. Eur. J. Biochem. 269:1181-1189. http://dx.doi.org/10.1046/j.0014-2956.2002.02751.x.
49. Schmidtchen A, Malmsten M. 2013. Peptide interactions with bacterial lipopolysaccharides. Curr. Opin. Colloid Interface Sci. 18:381-392. http://dx.doi.org/10.1016/j.cocis.2013.06.003.
50. Walker SL, Redman JA, Elimelech M. 2004. Role of cell surface lipopolysaccharides in Escherichia coli K-12 adhesion and transport. Langmuir 20:7736-7746. http://dx.doi.org/10.1021/la049511f.
51. Burks GA, Velegol SB, Paramonova E, Lindenmuth BE, Feick JD, Logan BE. 2003. Macroscopic and nanoscale measurements of the adhesion of bacteria with varying outer layer surface composition. Langmuir 19:2366-2371. http://dx.doi.org/10.1021/la026375a.
52. Boman HG, Monner DA. 1975. Characterization of lipopolysaccharides from Escherichia coli K-12 mutants. J. Bacteriol. 121:455.
53. Yanisch-Perron C, Vieira J, Messing J. 1985. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mpl8 and pUC19 vectors. Gene 33:103-119. http://dx.doi.org/10.1016/0378-1119(85)90120-9.
54. Datsenko KA, Wanner BL. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U. S. A. 97:6640-6645. http://dx.doi.org/10.1073/pnas.120163297.
55. Chao Y, Zhang T. 2011. Probing roles of lipopolysaccharide, type 1 fimbria, and colanic acid in the attachment of Escherichia coli strains on inert surfaces. Langmuir 27:11545-11553. http://dx.doi.org/10.1021/la202534p.
56. Parker CT, Pradel E, Schnaitman CA. 1992. Identification and sequences of the lipopolysaccharide core biosynthetic genes rfaQ, rfaP, and rfaG of Escherichia coli K-12. J. Bacteriol. 174:930-934.
57. Gronow S, Brabetz W, Brade H. 2000. Comparative functional characterization in vitro of heptosyltransferase I (WaaC) and II (WaaF) from Escherichia coli. Eur. J. Biochem. 267:6602-6611. http://dx.doi.org/10.1046/j.1432-1327.2000.01754.x.
58. Ruiz N, Gronenberg LS, Kahne D, Silhavy TJ. 2008. Identification of two inner-membrane proteins required for the transport of lipopolysaccharide to the outer membrane of Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 105:5537-5542. http://dx.doi.org/10.1073/pnas.0801196105.
59. Meredith TC, Mamat U, Kaczynski Z, Lindner B, Holst O, Woodard RW. 2007. Modification of lipopolysaccharide with colanic acid (Mantigen) repeats in Escherichia coli. J. Biol. Chem. 282:7790-7798. http://dx.doi.org/10.1074/jbc. M611034200.
60. Gottesman S, Trisler P, Torres-Cabassa A. 1985. Regulation of capsular polysaccharide synthesis in Escherichia coli K-12: characterization of three regulatory genes. J. Bacteriol. 162:1111-1119.